While alpha-fetoprotein (AFP) serves as a serological biomarker, its limitations are well-documented: low sensitivity (approximately 40% of HCC patients exhibit normal AFP) and susceptibility to non-tumor confounders (e.g., liver regeneration, pregnancy) (7). The gene discussed is AFP; the disease is hepatocellular carcinoma.